The effect of hot-tub therapy on serum Hsp70 level and its benefit on diabetic rats: A preliminary report

International Journal of Hyperthermia

Volumn 26, Issue 6, 2010, Pages 577-585

  Bathaie, S Zahra ^a   Jafarnejad, Akbar ^a   Hosseinkhani, Saman ^a   Nakhjavani, Manouchehr ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant capacity; Diabetic complications; HDL functionality; Hot tub therapy; Hsp70; Protein folding

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEAT SHOCK PROTEIN 70; INSULIN; LUCIFERASE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BATH; BLOOD SAMPLING; BODY WEIGHT; CONTROLLED STUDY; CORE TEMPERATURE; GLUCOSE BLOOD LEVEL; HOT TUB THERAPY; HYPERTHERMIC THERAPY; IN VITRO STUDY; INSULIN RELEASE; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; THERAPY EFFECT;

ANIMALS; BLOOD GLUCOSE; BODY TEMPERATURE; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; GLYCOSYLATION END PRODUCTS, ADVANCED; HEMOGLOBIN A, GLYCOSYLATED; HSP70 HEAT-SHOCK PROTEINS; HYPERTHERMIA, INDUCED; INSULIN; LIPIDS; MALE; RATS; RATS, WISTAR; STREPTOZOCIN; TREATMENT OUTCOME;

EID: 77955644253     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2010.485594     Document Type: Article

References (42)

1. Brownlee M. The pathological implications of proteins glyca-tion. Clin Inv Med 1995;18:275-281.
2. Singh R, Barden A, Mori T, Beilin L. Advanced glycation-end products: A review. Diabetologia 2001;44:129-146.
3. Peppa M, Uribarri J, Vlassara H. Glucose, advanced glycation end products, and diabetes complications: What is new and what works. Clin Diabetes 2003;21:4,186.
4. Rahbar S, Figarola JL. Novel inhibitors of advanced glycation endproducts. Arch Biochem Biophys 2003;419:63-79.
5. Agardh CD, Stenram U, Torffvit O, Agardh E. Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats. J Diabetes Complications 2002;16:395-400.
6. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci 1991;88:11555-11558.
7. Craig EA, Weissman JS, Horwich AL. Heat shock proteins and molecular chaperones: Mediators of protein conformation and turnover in the cell. Cell 1994;78:365-372.
8. Fleshner M, Johnson JD. Endogenous extra-cellular heat shock protein 72: Releasing signal(s) and function. Int J Hyperthermia 2005;21:457-471.
9. Mortaz E, Redegeld FA, Bloksma N,DunsmoreK, Denenberg A, Wong HR, Nijkamp FP, Engels F. Induction of Hsp70 is dispensable for anti-inflammatory action of heat shock or NSAIDs in mast cells. Exp Hematol 2006;34:414-423.
10. Yamagish N, Nakayama K, Wakatsuki T, Hatayama T. Characteristic changes of stress protein expression in streptozotocin-induced diabetic rats. Life Sci 2001;69: 2603-2609.
11. Kurucz I, Morva A, Vaag A, Eriksson KF, Huang X, Groop L, Koranyi L. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes 2002;51:1102-1109.
12. Hooper PL, Hopper JJ. Loss of defense against stress: Diabetes and heat shock proteins. Diabetes Thechnol Ther 2005;7:204-208.
13. Atalay M, Oksala NK, Laaksonen DE, Khanna S, Nakao C, Lappalainen J, Roy S, Hanninen O, Sen CK. Exercise training modulates heat shock protein response in diabetic rats. J Appl Physiol 2004;97:605-611.
14. Mendez JD, Ramos GHB. Animal models in diabetes research. Arch Med Res 1994;25:367-375.
15. Tolson JK, Roberts SM. Manipulating heat shock protein expression in laboratory animals. Methods 2005;35:149-157.
16. King Y-T, Lin C-S, Lin J-H, Lee W-C. Whole-body hyperthermia-induced thermotolerance is associated with the induction of Heat Shock Protein 70 in mice. J Experiment Biol 2002;205:273-278.
17. Ohno S, Siddik ZH, Baba H, Stephens LC, Strebel FR, Wondergem J, Khokhar AR, Bull JMC. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats. Cancer Res 1991;51:2994-3000.
18. Yamashita N, Hoshida S, Otsu K, Taniguchi N, Kuzuya T, Hori M. Involvement of cytokines in the mechanism of whole-body hyperthermia-induced cardioprotection. Circulation 2000;102:452-457.
19. Pritchard MT, Ostberg JR, Evans SS, Burd R, Kraybill W, Bull JM, Repasky EA. Protocols for simulating the thermal component of fever: Preclinical and clinical experience. Methods 2004;32:54-62.
20. Fridewald WJ, Levy RJ, Fredrikson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
21. Kalousova M, Skrha J, Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 2002;51: 597-604.
22. Benzie IF, Stain JJ. The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: The FRAP assay. Anal Biochem 1996;239:70-76.
23. Shaklai N, Garlick RL, Bunn HF. Nonenzymatic glycosyla-tion of human serum albumin alters its conformation and function. J Biol Chem 1984;259:3812-3817.
24. Szabo A, Langer T, Schroder H, Flanagan J, Bukau B, Hartl U. The ATP hydrolysis dependent reaction cycle of the Escherichia coli Hsp70 system-DnaK, DnaJ, and GrpE. Proc Natl Acad Sci USA 1994;91:10345-10349.
25. Jafarnejad A, Bathaie SZ, Nakhjavani M, Hassan MZ, Banasadegh S. The improvement effect of L-Lys as a chemical chaperone on STZ-induced diabetic rats, protein structure and function. Diabetes Metab Res Rev 2008;24:64-73.
26. Jafarnejad A, Bathaie SZ, Nakhjavani M, Hassan MZ. Investigation of the mechanisms involved in the high-dose and long-term acetyl salicylic acid therapy of type I diabetic rats. J Pharmacol Exp Ther 2008;324:850-857.
27. Jafarnejad A, Bathaie SZ, Nakhjavani M, Hassan MZ. Effect of spermine on lipid profile and HDL functionality in the streptozotocin-induced diabetic rat model. Life Sci 2008;82:301-307.
28. Hooper PL. Hot-tub therapy for type 2 diabetes mellitus. N Engl J Med 1999;341:924-925.
29. Capitano ML, Ertel BR, Repasky EA, Ostberg JR. Fever-range whole body hyperthermia prevents the onset of type 1 diabetes in non-obese diabetic mice. Int J Hyperthermia 2008;24:141-149.
30. Kokura S, Adachi S, Manabe E, Mizushima K, Hattori T, Okuda T, Nakabe N, Handa O, Takagi T, Naito Y, et al. Whole body hyperthermia improves obesity-induced insulin resistance in diabetic mice. Int J Hyperthermia 2007;23: 259-265.
31. Tanner JW, Eckenhoff RG, Liebman PA. Halothane, an inhalational anesthetic agent, increases folding stability of serum albumin. Biochim Biophys Acta 1999;1430:46-56.
32. Li X, Friedman AB, Roh M-S, Jope RS. Anesthesia and post-mortem interval profoundly influence the regulatory serine phosphorylation of glycogen synthase kinase-3 in mouse brain. J Neurochem 2005;92:701-704.
33. Horsman MR. Tissue physiology and the response to heat. Int J Hyperthermia 2006;22:197-203.
34. Perdrizet GA, Rewinski MJ, Schweizer RT, Scharp DW. Heat shock and recovery protects pancreatic islets from warm ischemic injury. Transplant Proc 1994;26:3477-3478.
35. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK. Novel signal transduction pathway utilized by extracellular Hsp70. Role of toll-like receptor (TLR)2 and TLR4. J Biol Chem 2002;277: 15028-15034.
36. Arispe N, Doh M, Simakova O, Kurganov B, De Maio A. Hsc70 And Hsp70 interact with phosphatidylserine on the surface of PC12 cells resulting in a decrease of viability. FASEB J 2004;18:1636-1645.
37. Yerbury JJ, Stewart EM, Wyatt AR, Wilson MR. Quality control of protein folding in extracellular space. EMBO Reports 2005;6:1131-1136.
38. Schmitt E, Gehrmann M, Brunet M, Multhoff G, Garrido C. Intracellular and extracellular functions of heat shock proteins: Repercussions in cancer therapy. J Leukoc Biol 2007;81:15-27.
39. Multhoff G. Heat shock protein 70 (Hsp70): Membrane location, export and immunological relevance. Methods 2007;43:229-237.
40. Browne CL, Swan JB, Rankin EE, Calvert H, Griffiths S, Tytell M. Extracellular heat shock protein 70 has novel functional effects on sea urchin eggs and coelomocytes. J Exp Biol 2007;210:1275-1287.
41. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53: 457-481.
42. Wilson MR, Easterbrook-Smith SB. Clusterin is a secreted mammalian chaperone. Trends Biochem Sci 2000;25:95-98.